TNF and COVID-19: This study demonstrated that even in the presence of microvascular and endothelial dysfunction followed by mild COVID-19 as well as during persistently elevated levels of proinflammatory cytokines and parameters of endothelial activation, such as TNFα and sICAM-1, serum ADA1 is not increased.